Professor Guillermo Montoya elected member of EMBO
Professor Guillermo Montoya from Novo Nordisk Foundation Center for Protein Research at the University of Copenhagen has been accepted into the prestigious research network EMBO, which counts 1,700 highly esteemed European researchers, including 87 Nobel Prize winners.
Today EMBO (the European Molecular Biology Organization) releases the list of new members who have been accepted into the acclaimed molecular biology network of researchers contributing to new, ground-breaking discoveries within the health and medical sciences.
The membership of Professor Guillermo Montoya from the Novo Nordisk Foundation Center for Protein Research honours his research, which through advanced biophysical technologies uncovers the structure of biomolecules and offers insight into how they work. This knowledge can be used to treat DNA damage and multi-protein complexes involved in various diseases, including cancer.
’I am very honoured to be accepted as a member of EMBO. It is a prestigious network allowing me to exchange experiences with the most talented researchers in the world. A couple of my colleagues from the research centre at SUND are already a part of EMBO, and I am sure the collaboration facilitated by EMBO can further strengthen results within protein research in Europe’, says Professor Guillermo Montoya.
Professors Jiri Lukas, Matthias Mann and Søren Brunak from the Novo Nordisk Foundation Center for Protein Research are also members of EMBO and they are happy to be able to welcome Montoya to the network.
‘Guillermo is a main driving force within protein research through highly advanced cryo-electron microscopy, and his results are vital to the research synergy here at the centre. I have no doubt that both he and his new research network will benefit greatly from his membership of EMBO’, says Managing Director of the Novo Nordisk Foundation Center for Protein Research Professor Jiri Lukas.
EMBO supports talented researchers at all career stages and stimulates exchange of experiences between the researchers in the network. The main objective is to strengthen excellent research results in Europe by bridging the gap between the most talented research capacities within the health and medical sciences. The network comprises 1,700 researchers, including 87 Nobel Prize winners.
’Montoya’s membership is based on “recognition of his contribution to scientific expertise” and as “praise for his research and results”’, says Director of EMBO Maria Leptin.
Montoya is Research Director of the Protein Structure and Function Programme at Novo Nordisk Foundation Center for Protein Research and Chairman of ISBUC (Integrative Structural Biology at the University of Copenhagen). In addition, Montoya is an active member of several international research networks, including the Scandinavian CryoNet collaboration.